UAMY - Beautiful Setup with Key Changes in Management
New CEO is Mr. Evans Evans has served for 24 years as a Director of Novavax Inc., a NASDAQ listed (“NVAX”) clinical-stage vaccine biotechnology company (Covid-19 Vaccine) with a market capitalization in excess of $15 Billion, and previously served as Chairman, CEO and Lead Director.
Gary Evans has been buying the stock and now owns 1millin share @ price of $0.45
Volume is really low at the moment but Money flow has been consistently +ve
with Golden star indicator on a daily which is a really bullish signal.
Currently showing under consolidation
Little bit of volume can really send it
5million share buyback was announced by the company in latest 10Q
Gary Evans has been buying the stock and now owns 1millin share @ price of $0.45
Volume is really low at the moment but Money flow has been consistently +ve
with Golden star indicator on a daily which is a really bullish signal.
Currently showing under consolidation
Little bit of volume can really send it
5million share buyback was announced by the company in latest 10Q
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.